Usefulness of the Yokohama Advanced Cardiopulmonary Help Team in patients with acute respiratory distress syndrome

Abstract

AbstractAimTo evaluate whether establishing an extracorporeal membrane oxygenation (ECMO) specialist team, termed the Yokohama Advanced Cardiopulmonary Help Team (YACHT), affected the outcomes and centralization of patients requiring ECMO in Yokohama‐Yokosuka regions.MethodsThis retrospective observational study included patients aged ≥18 years and treated with venovenous‐ECMO for severe acute respiratory distress syndrome (ARDS) from 2014 to 2023. The primary outcome was intensive care unit (ICU) mortality. The secondary outcomes included ICU‐, mechanical ventilator‐, and ECMO‐free days and complications during the first 28 days.ResultsThis study included 46 (12 without‐ and 34 with‐YACHT) patients. Among with‐YACHT patients, 24 were transferred to our hospital from other hospitals, 14 were assessed by dispatched ECMO physicians, and 9 were transferred after ECMO introduction. No without‐YACHT patients were transferred from other hospitals. With‐YACHT patients experienced coronavirus disease 2019‐associated respiratory failure more frequently (0 vs. 27, p < 0.001) and had higher Acute Physiology and Chronic Health Evaluation II scores (19 vs. 24, p = 0.037) and lower Respiratory Extracorporeal Membrane Oxygenation Survival Prediction scores (4 vs. 2, p = 0.021). ICU mortality was not significantly different between the groups (2 vs. 4, p = 0.67). ICU‐ (14 vs. 9, p = 0.10), ventilator‐ (11 vs. 5, p = 0.01), and ECMO‐free days (20 vs. 14, p = 0.038) were higher before YACHT establishment. The incidences of complications were not significantly different between the groups.ConclusionsMortality was not significantly different pre‐ and post‐YACHT establishment; however, it helped promote regionalization and centralization in Yokohama‐Yokosuka areas. We will collect more cases to demonstrate YACHT's usefulness.